Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Superficial vaginal epithelial cells are the dead, flattened, non-nucleated cells forming the most apical layer (stratum corneum) of the vaginal mucosal epithelium[1][3][5]. They result from terminal differentiation (cornification) of squamous cells, losing nuclei and organelles, and accumulating glycogen, mucins, and keratin proteins[1]. Their main functions are to act as a physical barrier, foster a microenvironment conducive to protective lactobacilli, and deter pathogen invasion by maintaining low pH and structural integrity[1][2][5]. They are shed periodically, influenced by estrogen levels, and are essential for vaginal health, though not a molecular therapeutic target themselves[2][4][5].
Estrogen: induces proliferation and glycogen production in epithelial cells, thickens epithelium, restores barrier and microflora-supporting functions Microbicides: aim to infiltrate the superficial epithelial layer to prevent infection by sexually transmitted pathogens
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Superficial vaginal epithelial cell (null).